Judith Robertson
Director/Board Member at DURECT CORPORATION
Net worth: 233 922 $ as of 2024-04-29
Network origin in Judith Robertson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 22 | |
| Subsidiary | Pharmaceuticals: Major | 21 | |
| Public Company | Pharmaceuticals: Major | 20 | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Judith Robertson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Private Equity Analyst | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | President Graduate Degree Graduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chief Operating Officer | |
| PDL BIOPHARMA, INC. | Biotechnology | President Director/Board Member Director of Finance/CFO | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| Stanford University | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Pharmascience, Inc.
 Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALZA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Director of Finance/CFO Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| ENLITIC, INC. | Packaged Software | Chief Executive Officer Chairman | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Vegenics Pty Ltd.
 Vegenics Pty Ltd. Medical/Nursing ServicesHealth Services Part of Opthea Ltd., Vegenics Pty Ltd. is an Australian company that provides medical research, development, and commercialization of biologic drugs. Vegenics was acquired by Opthea Ltd. on August 14, 2008 for $5.06 million. | Medical/Nursing Services | Corporate Secretary Corporate Secretary | |
| PHARMING GROUP N.V. | Pharmaceuticals: Major | Compliance Officer Chief Operating Officer | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Treasurer Corporate Officer/Principal | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| ARVO Foundation for Eye Research | Corporate Officer/Principal Director/Board Member | ||
| Baylor College of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Toronto | College/University | Graduate Degree Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| University of Denver | College/University | Undergraduate Degree Graduate Degree | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Undergraduate Degree Doctorate Degree | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Masters Business Admin | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
| EYENOVIA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| QUESTCOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistics
International
| United States | 40 |
| Canada | 4 |
| Australia | 4 |
| United Kingdom | 3 |
| Switzerland | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 15 |
| Commercial Services | 6 |
| Technology Services | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 296 |
| Corporate Officer/Principal | 190 |
| Independent Dir/Board Member | 86 |
| Undergraduate Degree | 50 |
| Director of Finance/CFO | 47 |
Most connected contacts
| Insiders | |
|---|---|
| Jon Saxe | 43 |
| Geoff Duyk | 42 |
| William Brody | 40 |
| Elizabeth Anderson | 24 |
| Dan Spiegelman | 24 |
| Julia Haller | 22 |
| Timothy Morris | 21 |
| Mohammad Azab | 21 |
| Gail Maderis | 20 |
| David Gryska | 20 |
| Hans Jörg Reinhardt | 20 |
| Peter García | 19 |
| Jeremy Levin | 18 |
| Lena Elisabeth Svanberg | 16 |
| Elizabeth Adefioye | 16 |
- Stock Market
- Insiders
- Judith Robertson
- Company connections
